Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Amgen	Gilead Sciences	Moderna	Biogen	BioNTech
Symbol	NASDAQ:AMGN	NASDAQ:GILD	NASDAQ:MRNA	NASDAQ:BIIB	NASDAQ:BNTX
Price Information
Current Price	$254.21	$66.54	$163.15	$274.04	$183.71
52 Week Range	Hold	Buy	Hold	Hold	Hold
MarketRank™
Overall Score	2.3	2.8	1.6	1.7	0.9
Analysis Score	2.2	4.3	2.2	2.1	1.2
Community Score	3.0	3.3	3.0	3.0	2.7
Dividend Score	2.5	3.3	0.0	0.0	0.0
Ownership Score	1.7	1.7	0.8	1.7	0.0
Earnings & Valuation Score	1.9	1.3	1.9	1.9	0.6
Analyst Ratings
Consensus Recommendation	Hold	Buy	Hold	Hold	Hold
Consensus Price Target	$255.62	$99.74	$156.88	$305.57	$106.50
% Upside from Price Target	0.55% upside	49.89% upside	-3.84% downside	11.51% upside	-42.03% downside
Trade Information
Market Cap	$146.06 billion	$83.78 billion	$65.35 billion	$41.26 billion	$44.37 billion
Beta	0.76	0.51	1.73	0.53	-1.74
Average Volume	2,723,255	8,289,934	12,035,364	1,201,762	2,495,841
Sales & Book Value
Annual Revenue	$23.36 billion	$22.45 billion	$60.21 million	$14.38 billion	$121.63 million
Price / Sales	6.25	3.73	1,085.30	2.87	364.79
Cashflow	$19.58 per share	$7.89 per share	N/A	$38.38 per share	N/A
Price / Cash	12.98	8.43	N/A	7.14	N/A
Book Value	$16.28 per share	$17.90 per share	$3.49 per share	$73.93 per share	$2.44 per share
Price / Book	15.61	3.72	46.75	3.71	75.29
Profitability
Net Income	$7.84 billion	$5.39 billion	$-514,020,000.00	$5.89 billion	$-200,540,000.00
EPS	$14.82	$6.14	($1.55)	$33.57	($0.95)
Trailing P/E Ratio	20.50	68.60	N/A	9.07	N/A
Forward P/E Ratio	14.95	9.49	15.61	10.90	13.33
P/E Growth	1.90	0.67	0.53	1.04	N/A
Net Margins	29.42%	5.48%	-242.73%	35.63%	-250.12%
Return on Equity (ROE)	95.55%	37.77%	-28.11%	51.00%	-66.72%
Return on Assets (ROA)	15.52%	12.76%	-20.31%	23.54%	-41.73%
Dividend
Annual Payout	$7.04	$2.84	N/A	N/A	N/A
Dividend Yield	2.77%	4.27%	N/A	N/A	N/A
Three-Year Dividend Growth	39.13%	30.77%	N/A	N/A	N/A
Payout Ratio	47.50%	46.25%	N/A	N/A	N/A
Years of Consecutive Dividend Growth	1 Years	1 Years	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	3.12%	1.65%	0.04%	0.69%	N/A
Current Ratio	2.28%	3.25%	2.43%	2.06%	4.07%
Quick Ratio	1.88%	3.15%	2.43%	1.79%	4.02%
Ownership Information
Institutional Ownership Percentage	75.23%	76.36%	51.21%	83.51%	10.75%
Insider Ownership Percentage	0.36%	0.13%	29.20%	0.54%	N/A
Miscellaneous
Employees	24,300	13,600	1,300	9,100	1,941
Shares Outstanding	574.55 million	1.26 billion	400.53 million	150.56 million	241.52 million
Next Earnings Date	7/27/2021 (Estimated)	7/29/2021 (Estimated)	8/4/2021 (Estimated)	7/28/2021 (Estimated)	5/10/2021 (Confirmed)
Optionable	Optionable	Optionable	Optionable	Optionable	Not Optionable

Source	Headline
	Pfizer and BioNTech to donate vaccine doses for athletes ahead of Tokyo Olympics in July - MarketWatch marketwatch.com - May 7 at 7:28 PM
	NC coronavirus update May 7: Pfizer and BioNTech begin application for full FDA approval of their COVID-19 vaccine - WTVD-TV abc11.com - May 7 at 7:28 PM
	Pfizer and BioNTech begin the process of seeking full U.S. approval for their Covid vaccine - CNBC cnbc.com - May 7 at 7:28 PM
	BioNTech (NASDAQ:BNTX) Upgraded by Zacks Investment Research to "Strong-Buy" marketbeat.com - May 7 at 5:32 PM
	Pfizer, BioNTech to provide COVID-19 vaccine to Olympic athletes - WTVB News wtvbam.com - May 7 at 2:28 PM
	Coronavirus: Pfizer, BioNTech start process to seek full FDA approval for COVID-19 vaccine - FOX13 Memphis fox13memphis.com - May 7 at 2:28 PM
	BioNTech (NASDAQ:BNTX) Trading Up 8.7% americanbankingnews.com - May 7 at 2:04 PM
	Pfizer/BioNTech seek full FDA approval for its COVID-19 vaccine, plus more virus news - Quad City Times qctimes.com - May 7 at 9:27 AM
	Coronavirus: Pfizer, BioNTech start process to seek full FDA approval for COVID-19 vaccine - WSOC Charlotte wsoctv.com - May 7 at 9:27 AM
	EU Set to Sign Off New Pfizer Vaccine Contract as Soon as Friday - Bloomberg bloomberg.com - May 7 at 9:27 AM
	CSafe Global provides thermal protection for Covid-19 vaccine shipments from BioNTech facility \| Supply Chain - Logistics Update Africa logupdateafrica.com - May 7 at 9:27 AM
	Pfizer, BioNTech seek full FDA approval for COVID-19 vaccine - Fox Business foxbusiness.com - May 7 at 9:27 AM
	Pfizer/BioNTech seek full FDA approval for their Covid-19 vaccine - CNN cnn.com - May 7 at 9:27 AM
	Is a Surprise Coming for BioNTech (BNTX) This Earnings Season? finance.yahoo.com - May 7 at 9:27 AM
	Pfizer/BioNTech jab confirmed to protect 95 per cent in largest study yet - CTV News ctvnews.ca - May 7 at 12:20 AM
	Pfizer, BioNTech to provide Covid-19 vaccine to Olympic athletes - NBC News nbcnews.com - May 7 at 12:20 AM
	BioNTech Stock Pares Deep Losses After Angela Merkel Opposes Waiving Patents - Investor's Business Daily investors.com - May 6 at 7:20 PM
	Pfizer and BioNTech to donate vaccines for Olympic athletes - KFGO News kfgo.com - May 6 at 7:20 PM
	Pfizer-BioNTech COVID-19 Vaccine Significantly Prevents Infection, Severe Disease in Israel - Contagionlive.com contagionlive.com - May 6 at 2:19 PM
	Moderna, BioNTech Lead Losses on Vaccine IP Waivers - Yahoo Finance finance.yahoo.com - May 6 at 2:19 PM
	Pfizer-BioNTech Can Supply 3 Billion Vaccine Doses This Year - Bloomberg bloomberg.com - May 6 at 2:19 PM
	Pfizer, BioNTech to provide COVID-19 vaccine to Olympic athletes - WHBL News whbl.com - May 6 at 2:19 PM
	BioNTech (NASDAQ:BNTX) Shares Gap Down to $170.77 americanbankingnews.com - May 6 at 1:34 PM
	Baillie Gifford & Co Buys Moderna Inc, The Trade Desk Inc, BioNTech SE, Sells Tesla Inc, ... gurufocus.com - May 6 at 12:24 PM
	BioNTech CEO says prospective 2021 vaccine output approaching 3 billion doses - KFGO News kfgo.com - May 6 at 1:54 AM
	Pfizer-BioNTech vaccine approved for kids 12 to 15 years old in Canada – Aldergrove Star - Aldergrove Star aldergrovestar.com - May 6 at 1:54 AM
	BioNTech (NASDAQ:BNTX) PT Raised to $118.00 at SVB Leerink marketbeat.com - April 19 at 8:34 AM
	The Latest: Romanians protest restrictions as cases top 1M marketbeat.com - April 10 at 5:22 PM
	The Latest: Lawmakers aim to limit state emergency powers marketbeat.com - April 10 at 4:05 PM
	The Latest: Indian states warn of COVID-19 vaccine shortages marketbeat.com - April 10 at 6:14 AM
	The Latest: Navajo Nation issues weekend stay-at-home order marketbeat.com - April 9 at 10:43 PM
	The Latest: Duke University to require vaccines by the fall marketbeat.com - April 9 at 7:26 PM
	How to Invest After a Turbulent 2020 Election (BNTX) marketbeat.com - November 23 at 5:51 PM
	COVID-19 Vaccine Results See AstraZeneca (LON:AZN) Slip a Bit (BNTX) marketbeat.com - November 19 at 12:08 PM

Date	Company	Brokerage	Action
5/4/2021	Amgen	Royal Bank of Canada	Lower Price Target
5/4/2021	Amgen	Credit Suisse Group	Lower Price Target
5/4/2021	Amgen	SVB Leerink	Lower Price Target
5/4/2021	Amgen	Atlantic Securities	Reiterated Rating
5/3/2021	Amgen	Oppenheimer	Lower Price Target
5/3/2021	Amgen	Morgan Stanley	Lower Price Target
4/29/2021	Amgen	Robert W. Baird	Reiterated Rating
4/29/2021	Amgen	Evercore ISI	Reiterated Rating
4/28/2021	Amgen	JPMorgan Chase & Co.	Reiterated Rating
4/28/2021	Amgen	The Goldman Sachs Group	Reiterated Rating
4/28/2021	Amgen	BMO Capital Markets	Lower Price Target
3/11/2021	Amgen	Barclays	Lower Price Target
5/7/2021	Gilead Sciences	Jefferies Financial Group	Reiterated Rating
4/30/2021	Gilead Sciences	Needham & Company LLC	Reiterated Rating
4/1/2021	Gilead Sciences	Sanford C. Bernstein	Upgrade
3/30/2021	Gilead Sciences	Redburn Partners	Upgrade
1/4/2021	Gilead Sciences	Guggenheim	Upgrade
12/22/2020	Gilead Sciences	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Lower Price Target
12/22/2020	Gilead Sciences	Smith Barney Citigroup	Lower Price Target
12/18/2020	Gilead Sciences	Truist Financial	Lower Price Target
12/15/2020	Gilead Sciences	Piper Sandler	Lower Price Target
5/7/2021	Moderna	Chardan Capital	Boost Price Target
3/4/2021	Moderna	Brookline Capital Management	Boost Price Target
2/26/2021	Moderna	Bank of America	Reiterated Rating
4/23/2021	Biogen	HC Wainwright	Reiterated Rating
4/19/2021	Biogen	Wedbush	Boost Price Target
2/17/2021	Biogen	Cantor Fitzgerald	Lower Price Target
2/5/2021	Biogen	DZ Bank	Downgrade
1/29/2021	Biogen	Stifel Nicolaus	Upgrade
12/1/2020	Biogen	William Blair	Reiterated Rating
11/9/2020	Biogen	Mizuho	Lower Price Target
11/9/2020	Biogen	Cowen	Downgrade
4/6/2021	BioNTech	Berenberg Bank	Set Price Target
12/14/2020	BioNTech	Canaccord Genuity	Boost Price Target
10/29/2020	BioNTech	Commerzbank	Initiated Coverage

(Data available from 5/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources